High Potency Methyl B-12 Lozenge 2500 mcg Natural Mango Peach
Solaray High Potency Methyl B-12 Lozenge offers a substantial dose of Vitamin B12 in its methylcobalamin form, providing 2,500 mcg per lozenge. This dosage is considered clinically relevant and is commonly used for individuals seeking to support B12 levels. The product has an N+ Score of 75, earning a C+ grade, which indicates a good quality supplement. Its key strengths are its 100% ingredient adequacy, ensuring the clinical dose is delivered, and excellent label transparency. As a single-ingredient product, its formula completeness is 50%, meaning it is highly specialized rather than a multi-vitamin. This supplement is well-suited for those specifically needing high-potency Vitamin B12 support.
About This Product
High Potency Methyl B-12 Lozenge 2500 mcg Natural Mango Peach by Solaray is a vitamins & minerals supplement containing 1 active ingredients. It has earned an N+ Score of 75/100 (Grade C+).
This product features a fully transparent label with individual ingredient amounts disclosed, and key ingredients are present at clinically effective doses based on peer-reviewed research.
Notable clinical-dose ingredients include Vitamin B12.
N+ Score Breakdown
Are key ingredients present at clinically effective doses based on research?
Does the product include all expected ingredients for its supplement category?
Are individual ingredient amounts clearly disclosed without proprietary blends?
Does the formula include a breadth of beneficial compounds from multiple pathways?
Strengths
- +Key ingredients at clinically effective doses
- +Fully transparent label with individual ingredient amounts disclosed
- +1 ingredient(s) at clinical dose levels
Weaknesses
- −Limited ingredient diversity compared to category norms
Ingredient Analysis (1 ingredients)
| Ingredient | Amount | Dose Adequacy |
|---|---|---|
| Vitamin B12 | 2500.000 mcg | Optimal |
Clinical ranges based on NIH ODS Fact Sheets and peer-reviewed research. Status indicates whether the amount meets evidence-based thresholds.